Paget's disease is a common bone disorder characterised by increased, disorganised bone turnover in affected areas with overgrowth of immature woven bone. It affects about 4% of the population over 40 years of age in the United Kingdom.' 2 Response to treatment for Paget's disease and arthritis was evaluated symptomatically and biochemically.
Results
Referral pattern. Of the 50 patients, general practitioners had initially referred 22 to orthopaedic surgeons (17 being later referred for consideration of medical treatment), 13 direct to a metabolic unit, 11 to physicians in other hospitals, 3 to rheumatologists, and 1 to a geriatrician. The mean duration of symptoms for the whole group before referral for specialist opinion was 4-9 years (range 2 months to 15 years). In the majority this was the time that elapsed before specific medical or surgical treatment was considered.
Presentation. Pain was the presenting symptom in 42 of the 50 patients (84%). Twenty-four patients presented with pain that was typically well localised to the site of clinical and radiological Paget's disease and was described as dull, nagging, or like 'toothache'. Pain was not relieved by immobilisation in any particular position. The finding of a deformed, thickened, tender long bone caused no diagnostic difficulty. The bones affected symptomatically, in order of frequency, were tibiae (7 patients), lumbar vertebrae (7 patients), pelvic bones (3 patients), humerus (1 patient) an.d radius (1 patient disease. Sacral Paget's disease was frequent in this group and was associated with blurring or obliteration of the sacroiliac joints. Miscellaneous presentation. Three patients presented with pain due to fracture of Pagetic bone, two with giddiness and ataxia secondary to severe skull involvement and platybasia, and one patient with painless deformity of the tibia.
Response to medical treatment. Of the 24 patients adjudged to have bone pain alone the 15 most severely affected were treated with calcitonin. All had a good response within three to six weeks. Normal dosage schedules for either porcine or salmon calcitonin were used (40-80 MRC units or 50-100 MRC units respectively three to six days per week). Patients with disease in a single bone responded particularly well, often with dramatic reduction in bone pain. At review nine were still receiving regular cacitonin. Six had discontinued therapy with little or no recurrence of bone pain, three on account of side effects of porcine or salmon calcitonin, of whom one was later maintained on human calcitonin (kindly donated by Ciba Laboratories). The other nine patients had milder bone pain and responded to simple analgesics, soluble aspirin, paracetamol, Distalgesic (dextropropoxylene and paracetamol), or non-steroidal antiinflammatory drugs (NSAIDs)-ibuprofen, naproxen, or indomethacin. Fourteen of 17 patients presenting with arthritic pain also received a trial of calcitonin. None gained significant improvement with calcitonin, nor could we detect a placebo response retrospectively. They responded partially to analgesics and NSAIDs. Of the 25 with hip arthritis four responded well to simple analgesia and eight to NSAIDs. Patients with knee or ankle arthritis responded poorly to NSAIDs. Other supportive measures consisted of physiotherapy and weight reduction.
Total hip replacement in Paget's disease. Seven of the 50 patients came to total hip replacement because of increasing pain and disability. The mean age at operation was 68 years and the mean follow-up postoperatively 4-7 years. There was an excellent result in three, and improvement of hip mobility and pain by 70% in one patient. Significant complications were seen in three: one patient developed a loose prosthesis one year after operation; the other two had marked para-articular ectopic new bone formation around the operated hips one to three years after operation.
Discussion
The present review, conducted exclusively among the symptomatic 5% of patients with Paget's disease,'-3 has assessed the probable origin of these symptoms, their pattern of presentation, and response to therapy. Pain was the principal presenting symptom, arising from bone in 48%, from arthritis in 24%, and occasionally from both (6%). These figures are remarkably similar to those reported by Altman and Collins,7 who studied 290 patients with Paget's disease and found 'rheumatic syndromes' were present in 83%, with bone pain in 47%. In our study the other patients presented with progressive hip stiffness (10%), fracture (6%), painless deformity (2%) and ataxia (4%).
Using Roper S6 suggested classification of OA hip into four patterns (see 'Methods of assessment'), we found that approximately half the patients with OA hip had changes (type 1) indistinguishable from idiopathic disease with superior joint space loss.
Some had primary generalised OA, including OA of the side of the pelvis unaffected by Paget's disease. The other half of the patients had radiological changes such as medial or concentric joint space loss, more strongly suggestive that Paget's disease was contributing to its-development. Indeed many of these had varus deformities of the Pagetic femoral neck, suggesting a more medially directed stress within the hip joint. Concentric joint space loss is usually associated with inflammatory disease of synovium and cartilage-for example in rheumatoid arthritis-but the possibility of such changes within arthritic joints associated with Paget's disease has not been investigated. The possible role of altered mechanics within the hip joint on the basis of bone disease also requires further study. Protrusio acetabuli was associated with the most severe changes in trabecular pattern, remodelling, and in some cases marked deformity of the femoral neck and head. This study has also shown the rarity of femoral Paget's disease alone with OA of the hip.
Total hip replacement has been carried out in patients with Paget's disease with considerable success.8 9 The present small, unselected group with longer follow-up than other studies shows a less favourable outcome, with loosening of the prosthesis and/or para-articular ossification in three of seven patients. Taylor et al. 1 ( found significant ossification after total hip replacement in 8-5% of patients with ankylosing spondylitis, 4% in idiopathic OA, and none with rheumatoid arthritis. The frequency of para-articular ossification after -total hip replacement in Paget's disease has not been previously reported, but the present incidence may be significant. None of these patients received preoperative treatment for Paget's disease to reduce bone vascularity, and excessive bleeding was not a complication. At present there does not appear to be any specific contraindication to hip replacement in this group of patients. Marked protrusio acetabuli, however, may make adequate fixation of the acetabular component difficult when the Pagetic bone is soft or the medial pelvic wall very thin.
Pain and stiffness in other joints (knee, wrist, ankle) were associated with distorted articular surfaces on x-ray due to the adjacent bone deformity. Other signs of joint inflammation were lacking. The frequency of lumbar pain and stiffness in the present series (36%) is consistent with that found in the two American studies,71' comparing closety with the 37% reported by Altman and Collins. However, symptomatic lumbar spondylosis was very common in patients without vertebral Paget's disease, while spinal Paget's disease alone may be asymptomatic. The similarity of back symptoms among those with and without spinal Paget's disease therefore made it difficult to determine the cause of back pain, a problem encountered by others.7 No patients had past or family histories compatible with ankylosing spondylitis, nor were syndesmophytes or bone fusions found in their lumbosacral spines. Obliteration of the sacroiliac joints in Paget's disease may be more due to bony distortion than to true inflammatory sacroiliitis, in keeping with other joint changes. The finding of Franck et al. 1 studying 55 patients with Paget's disease that hyperuricaemia, gouty arthritis, and calcific periarthritis were all common was not confirmed.
Multiple symptoms may plainly result from chronic polyostotic disease, and up to 60% of patients with symptomatic Paget's disease develop articular symptoms in its course. Effective therapy may depend on accurate localisation of all symptoms, and many patients have an overlap between articular and bone symptoms. Analgesics and nonsteroidal anti-inflammatory drugs remain the basis of treatment for arthritis, and there is no evidence yet that calcitonin will inhibit its development. In selected cases orthopaedic procedures may be indicated, including osteotomy for bone deformity and joint replacement for severe degenerative disease.
We are grateful to the many physicians and surgeons who referred their patients.
